Plasma levels of progesterone and oestradiol after injections of 17 -hydroxyprogesterone caproate during the luteal phase of the normal menstrual cycle.
D000328:Adult; D001667:Binding, Competitive; D002850:Chromatography, Gel; D003338:Corpus Luteum / Q000187:drug effects* / Q000502:physiology; D003864:Depression, Chemical; D004958:Estradiol / Q000097:blood*; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000008:administration & dosage / Q000494:pharmacology*; D007273:Injections, Intramuscular; D008598:Menstruation / Q000187:drug effects*; D010060:Ovulation / Q000187:drug effects*; D011374:Progesterone / Q000097:blood*; D011863:Radioimmunoassay; D013997:Time Factors
D006908:Hydroxyprogesterones; D011374:Progesterone; D004958:Estradiol